Exam 1 - 2nd half Flashcards
phase I reactions usually convert the parent drug to a more _____ metabolite by introducing/unmaksing a _____
polar
functional group
CYP reaction - aromatic and aliphatic hydroxylations need a _______ R group to make an adequate site for hydroxylation
electron-withdrawing
CYP reaction - epoxidation needs a _____ carbon carbon bond with adjacent ____
unsaturated
R-groups
CYP reaction - oxidative dealkylations can occur on 3 different types of groups
N-
O-
S-
CYP reaction - N oxidation can occur on what 3 types of amines? And it needs a ______ R group on the N
primary, secondary or tertiary amine
electron-withdrawing group
CYP reaction - deamination occurs with _____ amines with ____ groups attached to the N atom
primary amines
alkyl groups
FMO reactions prefer the oxidation or ___ and ____ amines to the hydroxyl amines and _-oxides, they also catalyze _-oxidations
secondary and teriatry amines
N-oxides
S-oxidations
FMO reaction - N-oxidation with ____ amines that have a small alkyl group attached, it forms a _______
tertiary
N-oxide
Glucuronidation and sulfation often occur on same substrates (3 kinds) ____ _____ ____, or 2 kinds of sulfates ____ & ____. N-conjugates occurs on ____ or ____ amines
N, S, C
N & O sulfates
primary or secondary amines
GSH conjugation - all GST substrates contain an _____ atom and are _____ substrates
electrophilic atom
hydrophobic
GSH conjugation - most electrophilic substrates must contain a ________ group
a good leaving group
N-acetylation by cytosolic NATS occurs on _____ amines, ______ groups or ___aminds
aromatic amines
hydrazine groups
sulfonamides
pharmacogenetics is the study of ______ controlled variations in drugs response. Includes both genetic _____ and ____ genetic ___ that alter an individuals drug response
genetically
polymorphisms
rare
disorders
genetic polymorphisms are define as a ____ or _____ trait that exists in the population in at least ___ phenotypes, neither which are ___
Mendialsn or monogenic trait
2
rare
additive (co-dominant)
most common pattern
no domination of one allele over another
gene dosage effect